It is studied whether immunity obtained by previous infection or vaccination with a human or swine influenza virus protects against subsequent infection with antigenically related or unrelated swine influenza virus. We focus on H3N2 swine influenza virus, a likely candidate for a future pandemic. Furthermore, we aim to improve the interpretation of serological tests against swine influenza viruses in humans.